“Advances in the Pharmacotherapy of Heart Failure: Type 2 Sodium-Glucose Cotransporter Inhibitors (SGLT2) As a Therapeutic Option”. 2023. Research, Society and Development 12 (3): e12412340502. https://doi.org/10.33448/rsd-v12i3.40502.